Cat. No.: HY-N6983

Licoricesaponin G2

Customer Review

Based on 1 Customer Validation

Licoricesaponin G2 is an orally active component found in Licorice. Licoricesaponin G2 significantly ameliorates Bleomycin (HY-108345)-induced pulmonary fibrosis by inhibiting the TNF-α signaling pathway, reducing epithelial-mesenchymal transition, and decreasing extracellular matrix deposition. Licoricesaponin G2 inhibits cancer cells proliferation, migration, inhibits PI3K/AKT/mTOR signaling pathway and increases ROS production. Licoricesaponin G2 can be used for the research of lung cancer and pulmonary fibrosis.

For research use only. We do not sell to patients.

Purity: 99.87%
CAS No.: 118441-84-2
Formula: C₄₂H₆₂O₁₇
Molecular Weight:838.93

Storage:

4°C, protect from light

* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

Licoricesaponin G2 Chemical Structure

CAS No.: 118441-84-2

Size

Price

Stock

Quantity

Amount: USD 0.00

* Please select Quantity before adding items.

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biological Activity
- Description
- Cellular Effect
- In Vitro
- In Vivo
Chemical Information
Solvent & Solubility
- In Vitro
- In Vivo
Purity & Documentation
References
Help & FAQs
Classifications
Bioz

Biological Activity

Description

All TNF Receptor Isoforms :

All PI3K Isoforms :

All Akt Isoforms :

All mTOR Isoforms :

Cellular Effect

Cell Line	Type	Value	Description	References
Hepatocyte	IC₅₀	6.9 μM Compound: 194	Hepatotoxicity in D-GaIN induced in Wistar rat model hepatocyte assessed as reduction in PLA2 level Hepatotoxicity in D-GaIN induced in Wistar rat model hepatocyte assessed as reduction in PLA2 level	[PMID: 29353722]

In Vitro

Licoricesaponin G2 (0.5-10 μM; 72 h) reduces the viability of NCI-A549, NCI-H460, and NCI-H446 lung cancer cells in a dose-dependent manner^[1].
Licoricesaponin G2 (1-5 μM; 14 days) dose-dependently inhibits colony formation in NCI-A549, NCI-H460, and NCI-H446 lung cancer cells^[1].
Licoricesaponin G2 (1-5 μM; 3 days) dose-dependently inhibits sphere formation in NCI-A549, NCI-H460, and NCI-H446 lung cancer cells^[1].
Licoricesaponin G2 (1-5 μM) dose-dependently downregulates cancer stem cell markers (CD44, CD133), PI3K/AKT pathway phosphorylated proteins (p-PI3K, p-AKT, p-mTOR), EGFR/STAT3 pathway phosphorylated proteins (p-EGFR, p-STAT3), and ferroptosis markers (SLC7A11, GPX4) in NCI-A549 and NCI-H446 lung cancer cells^[1].
Licoricesaponin G2 (1-5 μM; 48 h) increases the thermal stability of the PIK3R1 protein in NCI-A549 lung cancer cells^[1].
Licoricesaponin G2 (1-5 μM; 24 h) dose-dependently increases intracellular reactive oxygen species levels in NCI-H446 lung cancer cells^[1].
Licoricesaponin G2 (1-5 μM) dose-dependently increases MDA and GSH levels in NCI-H446 lung cancer cells^[1].
Licoricesaponin G2 (1-5 μM) inhibits 3D spheroid formation in NCI-H460 lung cancer cells and dose-dependently downregulates phosphorylated PI3K/AKT pathway proteins (p-PI3K, p-AKT, p-mTOR) in spheroids^[1].
Licoricesaponin G2 shows strong binding affinity to both TNF-α and MMP9 proteins, with docking scores of -4.849 kcal/mol and -6.392 kcal/mol, respectively^[2].
Licoricesaponin G2 (0.2-50 μM; 48 h) reduces viability of A549 human lung carcinoma cells, and also reduces viability of TGF-β₁-stimulated A549 and MRC5 cells at these respective concentrations^[2].
Licoricesaponin G2 (0.8-3.1 μM; 48 h) reverses TGF-β1-induced EMT and ECM accumulation in A549 human lung carcinoma cells by upregulating E-cadherin and downregulating N-cadherin, α-SMA, and Collagen I at both mRNA and protein levels^[2].
Licoricesaponin G2 (6.3-25 μM; 48 h) reverses TGF-β1-induced FMT and ECM accumulation in MRC5 human fetal lung fibroblasts by downregulating α-SMA and Collagen I at both mRNA and protein levels^[2].
Licoricesaponin G2 (0.8-1.6 μM; 24 h) inhibits TGF-β1-induced migration of A549 human lung carcinoma cells^[2].
Licoricesaponin G2 (0.8-12.5 μM; 48 h) inhibits the TNF-α signaling pathway in TGF-β1-stimulated A549 and MRC5 cells, reducing protein levels of TNF-α, p-IKK, p-NFκB, MMP3, and MMP9^[2].
Licoricesaponin G2 (0.05-1.0 mg/plate) does not exhibit antimutagenic activity against MNU in Salmonella typhimurium TA1535^[3].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay^[1]

Cell Line:

NCI-A549, NCI-H460, NCI-H446
Concentration:

0.5, 1, 2.5, 5, 10 μM
Incubation Time:

72 h
Result:

Significantly reduced the viability of A549, H460, and H446 cells at 5 and 10 μM.
Decreased viability in a dose-dependent manner.

Western Blot Analysis^[2]

Cell Line:

TGF-β1-stimulated A549 human lung carcinoma cells
Concentration:

0.8, 1.6 μM
Incubation Time:

48 h
Result:

Increased E-cadherin levles.
Reduced TGF-β1-increased N-cadherin, α-SMA and Collagen I levels.

In Vivo

Licoricesaponin G2 (10-50 mg/kg; daily; 21 days) dose-dependently inhibits growth of lung cancer NCI-A549 cells xenografts in mice^[1].
Licoricesaponin G2 (50 mg/kg; i.g.,; daily; 14 days) significantly ameliorates Bleomycin (HY-108345)-induced pulmonary fibrosis in male C57/BL6 mice by inhibiting the TNF-α signaling pathway, reducing epithelial-mesenchymal transition, and decreasing extracellular matrix deposition^[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:

BALB/c nude mice (female, 4-5 weeks old, 18-22 g, SPF, subcutaneous NCI-A549 cells xenograft model)^[1]
Dosage:

10 mg/kg; 50 mg/kg
Administration:

daily; 21 days
Result:

Reduced final tumor volume and tumor weight in a dose-dependent manner.
Reduced CD44 and CD133 protein levels in tumor tissue.
Reduced p-PI3K, p-AKT, and p-mTOR levels.

Animal Model:

C57/BL6 (8-week-old male, bleomycin-induced pulmonary fibrosis)^[2]
Dosage:

50 mg/kg
Administration:

p.o.; daily; 14 days
Result:

Reduced bleomycin-induced lung pathological changes including connective tissue proliferation, alveolar structure damage, and inflammatory cell infiltration.
Decreased collagen fiber deposition.
Upregulated E-cadherin protein expression and downregulated N-cadherin, α-SMA, and Collagen I protein expression.
Decreased α-SMA and Collagen I levels in lung tissue.
Reduced Bleomycin-induced increases in TNF-α, p-IKK, p-NFκB, MMP3, and MMP9 protein levels in lung tissue.

Chemical Information

CAS No. 118441-84-2
Appearance Solid
Molecular Weight 838.93
Formula C₄₂H₆₂O₁₇
Color White to off-white
SMILES

C[C@@]1([C@@]2([H])[C@@]3([C@@]([C@](C)([C@@H](O[C@@]4([H])[C@@H]([C@H]([C@H](O)[C@@H](C(O)=O)O4)O)O[C@]5([H])O[C@@H]([C@@H](O)[C@H](O)[C@H]5O)C(O)=O)CC3)CO)([H])CC1)C)[C@]6(C([C@@]7([H])[C@](C)(CC[C@@](C(O)=O)(C)C7)CC6)=CC2=O)C
Structure Classification
- Terpenoids
- Other Terpenoids
Initial Source
Shipping

Room temperature in continental US; may vary elsewhere.
Storage

4°C, protect from light

* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

Solvent & Solubility

In Vitro:

DMSO : 100 mg/mL (119.20 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

View the Complete Stock Solution Preparation Table

Preparing Stock Solutions

View the Complete Stock Solution Preparation Table

Concentration Solvent Mass

1 mg

5 mg

10 mg

Concentration

Solvent

Mass

1 mM

1.1920 mL

5.9600 mL

11.9199 mL

5 mM

0.2384 mL

1.1920 mL

2.3840 mL

10 mM

0.1192 mL

0.5960 mL

1.1920 mL

Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.

Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Molarity Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Concentration Concentration

Volume Volume

Molecular Weight Molecular Weight

Dilution Calculator

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

Concentration _(start) Concentration _(start)

Volume _(start) Volume _(start)

Concentration _(final) Concentration _(final)

Volume _(final) Volume _(final)

In Vivo:

Select the appropriate dissolution method based on your experimental animal and administration route.

Stock Solution Working Solution

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

Protocol 1

Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline

Solubility: ≥ 2.5 mg/mL (2.98 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

Protocol 2

Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)

Solubility: ≥ 2.5 mg/mL (2.98 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

Protocol 3

Add each solvent one by one: 10% DMSO 90% Corn Oil

Solubility: ≥ 2.5 mg/mL (2.98 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown). If the continuous dosing period exceeds half a month, please choose this protocol carefully.

Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL Corn oil, and mix evenly.

In Vivo Dissolution Calculator

Please enter the basic information of animal experiments:

Dosage Dosage
mg/kg
Animal Weight (Per Animal) Animal Weight (Per Animal)
g
Dosing Volume (Per Animal) Dosing Volume (Per Animal)
μL
Number of Animals Number of Animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Please enter your animal formula composition:

%
DMSO +

Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
%
+
+
%
Tween-80 + +
%
Saline +

The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).

Working solution concentration: 0.22 mg/mL

Purity & Documentation

Select Batch:

Purity: 99.98%

Assay: 99.98%

ee.: 99.98%

Data Sheet (285 KB)
SDS (394 KB)
- English - EN (394 KB)
- Français - FR (394 KB)
- Deutsch - DE (394 KB)
- Norwegian - NO (394 KB)
- Español - ES (394 KB)
- Swedish - SV (394 KB)
- Italian - IT (394 KB)
- Korean - KR (394 KB)
- Portuguese - PT (394 KB)
COA (2659 KB)
Elemental Analysis Report (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
Handling Instructions (2659 KB)

References

[1]. Yang X, et al. Based on network pharmacology and experiments to investigate the inhibitory effect of Licoricesaponin G2 on lung cancer tumor growth. J Ethnopharmacol. 2026;357:120950. [Content Brief]

[2]. Ma J, et al. Licoricesaponin G2 ameliorates bleomycin-induced pulmonary fibrosis via targeting TNF-α signaling pathway and inhibiting the epithelial-mesenchymal transition. Front Pharmacol. 2024;15:1437231. Published 2024 Sep 5. [Content Brief]

[3]. Inami K, et al. Antimutagenic components in Glycyrrhiza against N-methyl-N-nitrosourea in the Ames assay. Nat Prod Res. 2017;31(6):691-695. [Content Brief]

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Complete Stock Solution Preparation Table

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg
DMSO	1 mM	1.1920 mL	5.9600 mL	11.9199 mL	29.7999 mL
	5 mM	0.2384 mL	1.1920 mL	2.3840 mL	5.9600 mL
	10 mM	0.1192 mL	0.5960 mL	1.1920 mL	2.9800 mL
	15 mM	0.0795 mL	0.3973 mL	0.7947 mL	1.9867 mL
	20 mM	0.0596 mL	0.2980 mL	0.5960 mL	1.4900 mL
	25 mM	0.0477 mL	0.2384 mL	0.4768 mL	1.1920 mL
	30 mM	0.0397 mL	0.1987 mL	0.3973 mL	0.9933 mL
	40 mM	0.0298 mL	0.1490 mL	0.2980 mL	0.7450 mL
	50 mM	0.0238 mL	0.1192 mL	0.2384 mL	0.5960 mL
	60 mM	0.0199 mL	0.0993 mL	0.1987 mL	0.4967 mL
	80 mM	0.0149 mL	0.0745 mL	0.1490 mL	0.3725 mL
	100 mM	0.0119 mL	0.0596 mL	0.1192 mL	0.2980 mL

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent:

Product Name:
CAS No.:
Species:
Purity:
Quantity:

Licoricesaponin G2

Bioactive Compound Library Max

Bioactive Compound Library

Apoptosis Compound Library

Immunology/Inflammation Compound Library

Kinase Inhibitor Library

Metabolism/Protease Compound Library

NF-κB Signaling Compound Library

PI3K/Akt/mTOR Compound Library

Stem Cell Signaling Compound Library

Natural Product Library

Anti-Cancer Compound Library

Autophagy Compound Library

Anti-Aging Compound Library

Antioxidant Compound Library

Differentiation Inducing Compound Library

Glycoside Compound Library

Oxygen Sensing Compound Library

Ferroptosis Compound Library

Medicine Food Homology Compound Library

Terpenoids Library

Glycolysis Compound Library

Cytoskeleton Compound Library

Glutamine Metabolism Compound Library

Traditional Chinese Medicine Active Compound Library

Anti-Breast Cancer Compound Library

Anti-Lung Cancer Compound Library

Anti-Pancreatic Cancer Compound Library

Anti-Blood Cancer Compound Library

Anti-Cancer Metabolism Compound Library

Anti-Obesity Compound Library

Angiogenesis-Related Compound Library

Glucose Metabolism Compound Library

Anti-Liver Cancer Compound Library

Anti-Colorectal Cancer Compound Library

Anti-Cancer Natural Product Library

Antidepressant Compound Library

Anti-inflammatory Traditional Chinese Medicine Active Compound Library

Plant-Sourced Natural Product Library

Anti-Prostate Cancer Compound Library

Anti-Pulmonary Fibrosis Compound Library

Cancer Stem Cells Compound Library

Pain-Related Compound Library

Mitochondrial Protection Compound Library

Membrane Protein-targeted Compound Library

Membrane Receptor-targeted Compound Library

Autoimmune Disease Compound Library

Cytokine Inhibitors Library

Serine/Threonine Kinase Inhibitor Library

Anti-Hematopathy Compound Library

Anti-Ovarian Cancer Compound Library

Multi-Target Compound Library

Radioprotector Library

MCE Bioactive Compound Library

Natural Product Library Plus

Natural Product and Natural Product-Like Compound Library

Anti-Gastric Cancer Compound Library

Anti-Fibrosis Compound Library

Anti-Brain Cancer Compound Library

Tibetan Medicine Compound Library

Protein Kinase Compound Library

Non-Alcoholic Fatty Liver Disease (NAFLD) Compound Library

Cell Proliferation Compound Library

High-Throughput Bioactive Compound Library

High-Throughput Natural Product Library

Ancient Chinese Classical Formulas Traditional Chinese Medicine Active Compound Library

Anti-Rheumatic Arthritis Compound Library

Diarrhea-Related Traditional Chinese Medicine Active Compound Library

Mongolian Medicine Compound Library

Tonifying Traditional Chinese Medicine Monomer Compound Library

Lactylation Compound Library

Mass Spectrometry Natural Product Library

All TNF Receptor Isoforms

All PI3K Isoforms

All Akt Isoforms

All mTOR Isoforms

Biological Activity

Chemical Information

Solvent & Solubility

Purity & Documentation